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Abstract  
Anxiety disorders are among the most common psychiatric disorders in children and 
adolescents.  They commonly interfere with peer relationships, schooling and family 
life, and persist into adulthood if left untreated.  This paper gives an overview of the 
identification, assessment and treatment of anxiety disorders in youth.  Identification 
of anxiety disorders is often poor and many young people with anxiety disorders go 
untreated.  We present a brief review of the evidence base for pharmacological and 
psychological treatment approaches to the management of anxiety disorders in 
youth.  Both have been found to be effective in the treatment of anxiety disorders, 
although psychological treatments such as Cognitive Behavioural Therapy (CBT) are 
considered the first line treatment due to relative benefits in terms of patient safety 
and parental preference.  Low intensity CBT approaches such as bibliotherapy and 
online therapies are effective and have the potential to improve access to evidence 
based interventions.  CBT approaches have also been found to be effective with 
particular patient groups, such as those with long-term physical health conditions 
and autism spectrum disorders, who are at an increased risk of anxiety disorders.  
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Introduction 
Anxiety disorders are among the most common mental health disorders in youth, 
with prevalence rates between 9% to 32% during childhood and adolescence.  
Lifetime prevalence of anxiety disorders is estimated at 27%, with the average age of 
onset in childhood.   
 
Classification 
Anxiety disorders are characterised by excessive worries, fears and negative beliefs, 
avoidance of specific situations or objects, and physical symptoms such as 
increased heart rate, quicker and shallower breathing, sweating, chest or stomach 
pains. The diagnostic manual DSM-5 specifies a number of anxiety disorders 
including Separation Anxiety Disorder, Specific Phobia, Social Anxiety Disorder 
(previously Social Phobia), Generalised Anxiety Disorder, Panic Disorder, 
Agoraphobia, and Selective Mutism (see Table 1). “Panic attack” (sudden onset of 
intense fear with cognitive and physical symptoms such as heart palpitations, 
breathlessness, dizziness, derealisation and fear of dying) is included as a specifier 
that can be applied across the DSM-5 disorders, as it is recognised that panic 
attacks can be implicated in a range of disorders.  Unlike previous versions, DSM-5 
does not classify Obsessive Compulsive Disorder (OCD) and Post-Traumatic Stress 
Disorder (PTSD) as Anxiety Disorders (they are now listed under Obsessive-
Compulsive and Related Disorders, and Trauma-Related and Stressor-Related 
Disorders, respectively) and, accordingly, we will not discuss them further here.    
 
Although the specifics of each anxiety disorder vary (see Table 1), they share some 
common features. These include overestimation of the actual threat and danger 
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associated with the feared situation, underestimation of the individual’s ability to 
cope, and significant interference in normal life experiences such as friendships, 
school and family life.  
 
Impact 
Anxiety disorders cause significant interference with the day-to-day functioning of 
children and young people, affecting school performance, social functioning, family 
life, leisure activities and sleep.  It is also important to note that, if anxiety disorders 
are left untreated, they tend to run a chronic course and often persist into adulthood.  
Anxiety disorders typically co-occur, are often comorbid with other disorders such as 
depression, and predict the development of other serious mental health problems in 
later life such as depression, substance misuse and risk of suicide.  Given how 
common and damaging childhood anxiety disorders can be, it is important to ensure 
that these are promptly identified and appropriately managed using evidence-based 
treatments.  
 
Development and maintenance 
A multitude of factors has been implicated in the development and maintenance of 
childhood anxiety disorders.  Anxiety disorders tend to run in families, with anxious 
children more likely to have anxious parents than non-anxious children. Furthermore, 
children of parents with an anxiety disorder are 7 times more likely to have an 
anxiety disorder themselves, compared to children of parents with no psychiatric 
disorder.  This intergenerational transmission has led researchers to explore genetic 
links to anxiety disorders, with twin studies showing that approximately 40% of the 
variance in anxious symptoms is accounted for by heritability.  
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Child temperament is also thought to be an important factor in the development of 
anxiety disorders.  In particular, an inhibited temperament in early childhood is a risk 
factor for anxiety disorders in middle childhood and mid-adolescence. Other 
hypothesised vulnerability factors include information processing biases such as 
interpretation of ambiguous situations as threatening and heightened attention 
towards potentially threatening environmental cues.  Environmental factors have also 
been implicated, including adverse life events and exposure to negative information 
or modelling of anxious responses.  Recent studies have suggested that anxious 
children can be particularly attuned to this information.  Furthermore, child 
characteristics can elicit certain parental behaviours such as overprotection, which 
although well intended and understandable, may serve to maintain anxiety as they 
may allow the child to avoid anxiety-provoking situations.  The main takeaway 
message from all of this is that the development of anxiety disorders in youth is 
typically underpinned by a complex interplay of several factors. 
 
 
Management of anxiety disorders in children and young people 
Seeking help 
Children and adolescents with anxiety problems do not usually seek help from 
medical professionals themselves.  Instead, concerns are more likely to be raised by 
their parents, for example to their General Practitioner (GP) or other professionals 
(e.g. school staff).  Rates of help seeking for anxiety disorders appear to be lower 
than for other mental health problems in childhood and the reasons for this are not 
well understood. Common barriers that prevent parents from seeking help for their 
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child in relation to mental health concerns more generally include a lack of 
knowledge and understanding of mental health problems and the help seeking 
process, family circumstances (e.g. limited time and competing commitments), 
negative attitudes towards service providers and treatment, and perceived difficulties 
with the mental health system (e.g. long waiting times and a lack of appointment 
flexibility). The specific barriers to help-seeking in the context of child and adolescent 
anxiety disorders remain unclear. 
 
Identification of potential anxiety disorders in children and young people 
GPs (alongside Common/Single Point of Entry services) have a gatekeeper role in 
relation to Child and Adolescent Mental Health Services (CAMHS) and therefore 
recognition and appropriate management within the GP consultation is key for the 
timely detection of anxiety disorders and access to effective interventions.  Despite 
this, studies have found that GPs are often poor at recognising mental health 
problems in young people, especially if parents do not raise concerns.  Anxiety can 
often present as somatic complaints in children (e.g. stomach aches and 
headaches), and young people may not be as forthcoming as adults in bringing up 
mental health issues, making anxiety all the more difficult to identify. In addition, GPs 
report that a lack of confidence, knowledge, time, providers and resources also 
reduce their ability to detect anxiety and their willingness to refer children and young 
people for treatment.   
 
Once anxiety is identified as a potential area of concern, assessment of (i) the 
severity and duration of symptoms and (ii) the associated impairment will enable the 
GP to determine whether fears and worries are likely to be developmentally 
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appropriate or indicate an anxiety disorder. Thus if the level of anxiety is high and 
disproportionate to the actual threat involved from the feared situation or stimulus, 
and these difficulties have persisted for several months and cause significant 
interference in the young person’s daily functioning e.g. peer relationships, 
schoolwork, school attendance or family life, a referral for further assessment by 
specialist services is indicated.  Unfortunately, no brief screening measures for 
childhood anxiety disorders are currently available.  However, there are freely 
available parent and child-report questionnaire measures, such as the Revised 
Children’s Anxiety and Depression Scale (RCADS; 47 items), which can be reliably 
used in children aged 7 years and above. The RCADS has subscales that broadly 
align with the different diagnostic categories and clinical cut-off scores are provided.  
The RCADS also involves questions about low mood, a common comorbid problem.   
 
Assessment of anxiety disorders in children and young people 
The National Institute of Health and Care Excellence (NICE) guidelines for the 
assessment and treatment of anxiety disorders have primarily focused on adults. 
However, the recent NICE guidelines for social anxiety disorder includes 
recommendations for children and adolescents, and some of the broader principles 
may be applied to other anxiety disorders.  NICE recommends that a comprehensive 
assessment should be undertaken by an appropriate healthcare professional.  The 
young person should have the opportunity to be interviewed on his or her own, 
however the parent(s) or carer(s) should also be included in the assessment as they 
are valuable informants.  Because young people with anxiety disorders commonly 
experience comorbid conditions, in addition to assessing anxiety related symptoms 
and disturbance, the assessment should also cover other typically co-occurring 
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mental health difficulties (e.g. mood disorders) as well as neurodevelopmental 
conditions, alcohol and substance misuse. 
 
In the UK, CAMHS routinely assess and monitor anxiety and mood symptoms using 
the RCADS as part of the Children and Young People’s Improving Access to 
Psychological Therapies Programme (CYP IAPT).  This is an initiative that began in 
2011 which aims to ensure that families receive an evidence-based and outcome-
focused service in CAMHS. 
 
The presence of an anxiety disorder (rather than anxiety symptoms) can be 
assessed using structured clinical interviews, such as the Anxiety Disorders 
Interview Schedule for children and parents (ADIS-C/P).  The current version aligns 
with DSM-IV criteria and considers whether a child meets criteria for a specific 
anxiety diagnosis based on symptoms and the associated level of interference with 
functioning.  
 
Treatment of Anxiety Disorders in Children and Young People 
 
Accessing treatment 
In the UK, treatment for childhood anxiety disorders is typically accessed through 
local CAMHS.  Although it is not uncommon for children and adolescents to receive 
input from other services provided by the local authority, charity organisations or 
school staff, these services may not be subject to the same requirements to deliver 
evidence-based treatments.  
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Evidence-based treatments 
The majority of randomised controlled trials (RCTs) for the treatment of anxiety 
disorders in children and adolescents have evaluated pharmacotherapy and/or 
Cognitive Behavioural Therapy (CBT).  Research into other approaches such as 
systemic therapy and psychodynamic therapy is lacking and little is currently known 
about their efficacy and effectiveness.    
 
Pharmacotherapy 
There is some evidence to suggest that anxiolytic medication is an effective 
treatment for anxiety disorders in combination with CBT or alone, although none are 
currently licensed in the UK for use with young people with anxiety disorders. The 
majority of treatment trials have evaluated selective serotonin reuptake inhibitors 
(SSRIs), and this is considered to be the first line pharmacotherapy.  While recent 
studies have suggested that SSRIs are generally safe and tolerable, they are 
associated with more physical adverse events (such as headache, insomnia and 
sedation) than CBT, especially in preadolescent children. Furthermore, the optimum 
treatment duration and the clinical consequences of stopping medication have yet to 
be evaluated.  Perhaps in reflection of these limitations, parents tend to report a 
preference for psychological interventions over medication for the treatment of 
anxiety disorders in children and young people.  As such, the NICE guidelines for 
social anxiety disorder recommend that CBT is the first-line treatment for anxiety 
disorders in children and young people and that pharmacological interventions are 
not routinely prescribed (i.e. they should only be offered within specialist services). 
Whilst specific guidelines for other anxiety disorders have yet to be published, the 
literature on which these recommendations were based was not specific to social 
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anxiety disorder and as such they can be considered applicable across the range of 
anxiety disorders that are experienced by children and young people. 
         
Cognitive Behavioural Therapy (CBT) 
CBT is a psychological therapy based on the theory that interconnectivity between 
thoughts, feelings and behaviours maintains difficulties such as anxiety.  For 
example, when faced with their parent going out for the evening, a child with 
separation anxiety disorder may think that their parent will get hurt in a car accident, 
leading to worry and scared feelings, physical symptoms such as agitation and 
attempts to avoid the situation, for example, by repeatedly asking their parent not to 
go out.  Understandably, both young people and adults alike tend to avoid situations 
that make them feel anxious, and consequently the anxiety reduces in the short-
term.  However, this can prevent the child or adolescent from having the opportunity 
to learn that (i) the feared outcome may not happen and (ii) they can cope with the 
challenge.  So when a similar situation arises in the future, they feel anxious and the 
cycle is repeated.  CBT looks at how to break unhelpful patterns by focusing on what 
is maintaining the difficulty, rather than what caused the problem.  For example, it 
may be that the start of the child’s separation anxiety could be traced back to a close 
friend having a car accident, which is helpful in understanding the context of the 
difficulties they are experiencing, but a specific focus on this is not necessary in 
order to break the links between the thoughts, feelings and behaviour that are 
maintaining the difficulties in the here and now.   
 
Due to the high level of comorbidity between anxiety disorders in children and 
adolescents, CBT has tended to be generic in its approach, rather than focused on a 
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specific disorder. Generic CBT approaches have been particularly influenced by the 
manualised CBT “Coping Cat” programme that was developed by Philip Kendall in 
the US, and typically involve psychoeducation, identification and modification of 
anxious thoughts through cognitive restructuring, graded exposure to the feared 
object or situation, relaxation techniques and problem solving.  CBT for anxiety 
disorders usually involves between 9 to 20 individual face-to-face CBT sessions with 
the child or adolescent. Although it is not clear which of these components are 
necessary or sufficient in treatment, exposure to the feared stimulus or situation (i.e. 
‘facing fears’) appears to be particularly important.   
 
Numerous studies have evaluated the effectiveness of CBT for anxiety disorders in 
children and adolescents.  Most of these have compared CBT to a waitlist control 
group, although a few studies have included an active control condition such as 
educational support.  A recent Cochrane Review concluded that CBT was 
significantly more effective than a waitlist control for a range of childhood anxiety 
disorders. Indeed, systematic reviews consistently report that CBT results in 
recovery from diagnosis of a primary anxiety disorder in approximately 60% of cases 
immediately after treatment, and this proportion rises to around 70% in the following 
6 to 12 months.  CBT has not consistently been found to be superior to active control 
interventions, highlighting the fact that ongoing work is needed to establish what the 
critical ingredients of effective treatments are and to improve treatment outcomes. 
However, CBT is currently the only psychological therapy that has been shown to be 
effective in a number of randomised controlled trials, and as such it is recommended 
as the first-line treatment for childhood anxiety disorders.  CBT appears to be 
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similarly effective whether delivered individually face to face or within a group, and 
with and without parental support.   
 
As noted above, approximately 40% of young people retain their primary anxiety 
disorder diagnosis after CBT yet it remains unclear why some young people do not 
respond while others do.  Small-scale studies have failed to find consistent 
predictors of treatment outcome, however an international multisite and multi-trial 
study of 1519 children and young people recently concluded that a diagnosis of 
social anxiety disorder, presence of a comorbid externalising or internalising 
disorder, and parental psychopathology predicted poorer treatment outcomes.  Age, 
gender and treatment type (individual, group, self-help) did not predict response to 
CBT.  Some approaches to improve outcomes for young people with a relatively 
poor prognosis include CBT programmes that incorporate social skills training and 
disorder-specific Cognitive Therapy for children and adolescents (respectively) with 
social anxiety disorder, although larger studies are needed. 
 
Treatment trials have typically evaluated CBT amongst children and adolescents 
covering broad age ranges, usually from about 7 years, and similar treatments are 
used across the age range (with some adaptations to make them more ‘teen-
friendly’). Although a recent meta-analysis concluded that adolescents showed 
comparable benefits to younger children after CBT, a subsequent large treatment 
trial found that adolescents with anxiety disorders had significantly poorer treatment 
outcomes, than anxious children. There are a number of reasons why this may be 
the case, including that adolescents tend to have more severe symptoms, greater 
comorbidity with mood disorders and more frequent school refusal than children 
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presenting with anxiety disorders, all factors that have been linked to relatively poor 
treatment outcomes. Nonetheless, some treatments that were originally designed for 
adults have recently been successfully adapted for use with adolescents and in the 
case of social anxiety disorder this has had extremely promising results.  
 
Low intensity treatments 
Low intensity treatments involve providing the least possible therapeutic input 
possible while maintaining treatment efficacy, and are designed to be used within a 
stepped model of care delivery, where more intensive treatments are reserved for 
those who require greater input or do not respond to lower intensity treatments.  CBT 
can be successfully delivered in less intense forms such as through guided self-
help/bibliotherapy (providing written materials to parents to enable them to use CBT 
strategies with their child with therapist support) and via computer-based 
programmes (CCBT) or online (“e-therapies”).  Numerous studies have shown that 
these ways of delivering treatment can produce similar results to more intensive 
individual child treatments or face-to-face therapies, although few studies have made 
this direct comparison. 
 
For preadolescent children, using written materials to work through parents rather 
than directly with the child brings many benefits such as the ability for parents to 
implement the strategies beyond the therapy sessions and as and when anxieties 
emerge after therapy ceases. In addition, children do not have to miss school or 
activities to attend therapy, and it prevents the child from experiencing stigma 
associated with attending therapy.  In the UK, we have shown that a brief (5 and a 
half hours) therapist-guided self-help programme delivered to parents of children 
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aged 7-12 years old is effective in reducing the number of children who have an 
anxiety disorder, with similar outcomes to those typically achieved with 12-16 hours 
of individual child CBT.  Furthermore, treatment outcomes did not differ in those 
supported by a “novice” CBT therapist (e.g. psychology graduates) compared to an 
experienced clinician (e.g. a Clinical Psychologist), supporting the use of this 
approach within a stepped care model of treatment delivery. 
 
Delivering psychological treatments online (“e-therapies”) also has the potential to 
increase access to evidence-based treatments and improve the efficiency and cost-
effectiveness of services.  A plethora of mental health related smartphone/tablet 
applications (“apps”) are available, although we are not aware of any specifically 
aimed at treating anxiety disorders in youth that have an evidence-base.  Platforms 
for accessing therapy online (e.g. Kooth.com) are commissioned within some NHS 
Trusts, however it is yet to be demonstrated whether accessing psychological 
therapies online in this manner is effective for treating childhood anxiety disorders. 
However, a handful of online (e.g. BRAVE-online) or computer-based (e.g. Camp 
Cope-A-Lot) treatments specifically for anxiety disorders in children and adolescents 
have been developed and evaluated in randomised controlled trials, predominantly 
within Australia and the US.  Studies consistently indicate that these produce similar 
outcomes to face-to-face treatments (though again direct comparisons are sparse) in 
reducing the number of children and adolescents who meet criteria for an anxiety 
diagnosis.  Whilst encouraging, these interventions often struggle to make it past the 
arena of academic evaluation, and dissemination into the NHS is rare.  Despite this, 
service users have an appetite for accessing therapy online and there is growing 
recognition that academics, clinicians and industry need to work together to develop, 
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evaluate and disseminate e-therapies.  NICE is currently working on guidelines 
relating to the level of evidence needed for the endorsement of mental health apps 
and online treatments, which should bring clarity and guidance to the commissioning 
of e-therapies.            
 
Early intervention/prevention 
There is a clear argument for intervening early with anxiety disorders due to their 
chronic nature.  Selective interventions that target young children with known risk 
factors for anxiety disorders have started to emerge.  In Australia, an intervention 
targeted at pre-schoolers with an inhibited temperament (i.e. behaviourally inhibited, 
socially withdrawn, shy) successfully changed the expected trajectory of this at-risk 
group and lowered the frequency and severity of anxiety disorders that developed 
during a 3-year period compared to yearly monitoring.  Such selective interventions 
show promise but have yet to be evaluated in the UK.   
 
Universal (rather than targeted towards at-risk groups) early intervention 
programmes for school-aged children have been conducted in school settings, 
where the intervention is applied at the school level by either trained health 
professionals or school staff.  One such programme (“Friends”) was recently 
evaluated in the UK in a large (n=1257) multi-school study and the ‘Friends’ 
programme was associated with a reduction in overall anxiety scores compared to 
usual school provision.  However, scores only reduced significantly for those children 
who had lower anxiety scores at baseline and when health professionals (not school 
staff) delivered the programme, and group differences were not maintained at a two-
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year follow-up.  Such interventions are also problematic as they are resource 
intensive and may be financially prohibitive for schools.  
 
Special populations  
Long-term physical health conditions 
Children and young people suffering from chronic physical illness have up to four 
times the rate of psychiatric disorder compared to those without.  Rates for anxiety 
disorders specifically are similar, for example up to a third of young people with 
asthma, 13 – 48% of children with epilepsy, 39% of young people with Crohn’s 
disease, and around 50% of adolescents with cystic fibrosis meet criteria for an 
anxiety disorder.  Notably, children and adolescents with comorbid anxiety and 
physical health conditions have greater functional impairment than would be 
observed with either disorder alone.  Clinicians typically perceive children and 
adolescents with physical and mental health conditions as complex, with the 
management of their physical health often taking priority. Management using 
medication is often not considered appropriate as trials typically exclude young 
people with long-term physical health conditions and there is a greater risk of 
adverse medication effects and drug interactions in these children. Interventions that 
have been evaluated in this group have been based on CBT protocols adapted from 
those validated for use with physically well children and young people with anxiety 
disorders.  Adaptations to the CBT approach have been relatively minor and include 
a slower pace of (and therefore longer) sessions with greater emphasis on 
behavioural rather than cognitive aspects, extra written materials, more concrete 
language, and flexibility in treatment location e.g. use of telephone sessions or 
sessions at home, and have not usually involved specialist knowledge about the 
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illness.  Overall, these treatments have resulted in positive outcomes, and whilst 
larger RCTs are needed, the findings to date suggest that it is possible to use 
existing evidence-based CBT programmes to effectively treat anxiety disorders in 
children and young people with long-term physical illnesses.       
 
Autism Spectrum Disorders (ASD) 
Anxiety disorders are one of the most commonly occurring psychiatric conditions in 
young people with ASD, with recent studies indicating that approximately 40% of 
children and adolescents with ASD meet criteria for at least one anxiety disorder.  
The increased risk for anxiety in ASD is poorly understood.  Furthermore, the 
measurement of anxiety in this population is complicated by the overlapping 
symptoms of anxiety and ASD e.g. social avoidance and rigidity.  As such, it is 
unclear how best to unravel what aspects of anxiety are part of the ASD profile (e.g. 
anxiety related to transitions) and what reflect a separate anxiety disorder.  Child 
self-report in this population may also be compromised by difficulty in labelling and 
recognising internal emotional states, and therefore multi-informant approaches to 
assessment are critical.   
 
There is very little evidence regarding the effectiveness of pharmacotherapy in 
young people with ASD, however studies have shown that there is an increased risk 
for behavioural activation from SSRIs in this group.  Medication is therefore not 
recommended as the first-line treatment for anxiety disorders in children and 
adolescents with ASD, and side effects should be closely monitored if used.  
Systematic reviews have highlighted that few psychological treatments have been 
developed specifically for anxiety disorders in young people with ASD.  Interventions 
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that have been evaluated are mainly based on modified CBT programmes and 
conducted in samples of young people with high functioning ASD.  Encouragingly, 
treatment outcomes in this group are similar to those in typically developing children, 
with 71.4% of children recovering from their primary anxiety diagnosis following 
treatment.   
 
Summary and conclusions 
Anxiety disorders are common in childhood and adolescence, run a chronic course, 
are comorbid with other serious mental health difficulties and have a significant and 
enduring impact on functioning.  Prompt recognition, assessment and evidence-
based treatment are therefore crucial.  Anxiety disorders are particularly high in 
children and adolescents with long-term physical health conditions and those with 
autism spectrum disorders.  GPs and Paediatricians are well placed to identify 
anxiety difficulties, and refer onwards for appropriate management.  Anxiety 
disorders can be treated effectively by CBT and/or medication (SSRIs), although 
CBT is recommended as the first-line treatment due to it being associated with fewer 
safety concerns than SSRIs, as well as being the preferred treatment among 
parents.  Low-intensity approaches to CBT such as therapist-supported bibliotherapy 
and online treatments have the potential to increase access to evidence-based 
treatments and are likely to be cost-effective. 
 
Practice Points 
 Anxiety disorders are among the most common mental health disorders in 
childhood and adolescence and have a significant and enduring impact on social, 
academic and family functioning. 
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 There are established questionnaire measures that can be used to assess 
symptoms of anxiety disorders in primary case, although a brief screening tool 
has yet to be developed.   Referrals should be made to CAMHS for further 
specialist assessment. 
 Cognitive behavioural therapy (CBT) is the first line treatment. This can be 
delivered in a range of ways and by a variety of trained professionals.  Although 
CBT is effective, most children do not access treatment. 
 Anxiety disorders are particularly prevalent in children and adolescents with 
chronic physical health problems and young people with autism spectrum 
disorders (ASD).  However, there is some evidence to suggest generic 
treatments can be successfully applied to these populations.   
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Table 1. Common anxiety disorders in childhood and adolescence 
Disorder Symptoms Prevalence (%)1 Median age (y) of onset 
Separation Anxiety 
Disorder 
Anxiety when apart from (usually) a 
primary caregiver due to the fear that 
something bad will happen to either 
themselves or the attachment figure. 
1.17 7 
Specific Phobia Intense fear of a particular object or 
situation e.g. having injections. 
1 7 
Social Anxiety 
Disorder 
Anxiety in everyday social situations 
and social interactions due to a fear 
of negative evaluation by others. 
0.32 13 
Generalised Anxiety 
Disorder (GAD) 
Excessive and uncontrollable worry 
about a range of things that may or 
may not happen or have happened. 
0.65 31 
Panic Disorder Involves recurrent panic attacks, 0.14 24 
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which are feelings of terror that occur 
suddenly and without warning, 
accompanied by physical symptoms 
such as chest pain, palpitations, 
sweating and feeling of choking. 
Agoraphobia The fear of actual and anticipated 
places or situations that might result 
in a panic attack and often involves a 
belief that there is no easy way to 
escape or seek help. 
0.07 20 
Selective mutism Someone who is capable of speech 
and understanding language but 
does not speak in specific situations 
or to specific people 
0.502 Mean range = 2.7 to 4.1 
1Figures represent point prevalence (proportion who meet criteria for a diagnosis at a specific point in time) 
2This figure is taken from a different study to the other disorders.  It is higher than might be expected, possibly due to 
methodological differences between the studies.  
